Scott Glenn

Scott Glenn

Chief Executive Officer at
Kanisa Pharmaceuticals, Inc.
75 year
Health Technology
Process Industries
Health Services

Profile

Scott L.
Glenn
is the founder of Zogenix, Inc. (2006), Somaxon Pharmaceuticals, Inc. (2003),.
Evoke Pharma, Inc. (2007), Prometheus Laboratories, Inc. (1995), and ALASTIN Skincare, Inc. (2015).
Mr. Glenn is also the founder of SkinMedica, Inc., NovaCardia, Inc., Mallinckrodt Hospital Products, Inc., Conception Technologies LP, Spine Wave, Inc., Santarus, Inc., Avera Pharmaceuticals, Inc., Kanisa Pharmaceuticals, Inc., DexCom, Inc. Current jobs include Director at Planet Biopharmaceuticals, Inc., Director at Prometheus Laboratories, Inc., and General Partner at Glenn Holdings LP.
Former jobs include President & Chief Executive Officer at Quidel Corp., Chairman & Chief Executive Officer at Exagen, Inc., Director at Oculir, Inc., Director at Kalyra Pharmaceuticals, Inc., Director at Tokalas, Inc., Director at Allergy-Free LLC, Managing Director at Windamere Venture Partners LLC (1998-2009), Director at Oncternal Oncology, Inc., Director at Prometheus Biosciences, Inc. (2019-2020), Division General Manager at Allergan, Inc., and President at Planet Polymer Technologies, Inc. Education includes an undergraduate degree from California State University-Fullerton.

Scott Glenn active positions

CompaniesPositionStart
Chief Executive Officer -
Director/Board Member -
Corporate Officer/Principal -
Director/Board Member -

Former positions of Scott Glenn

CompaniesPositionEnd
PROMETHEUS BIOSCIENCES, INC. Chief Executive Officer 05/09/2019
EVOKE PHARMA, INC. Founder 02/05/2019
Chief Investment Officer 30/11/2009
Director/Board Member 23/10/2008
Founder 31/05/2007
See the detail of Scott Glenn's experience

Training of Scott Glenn

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

45

1st degree connections

28

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies28

Health Technology

Health Technology

Process Industries

Health Technology

Distribution Services

Health Technology

Health Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Services

Finance

Process Industries

Consumer Non-Durables

Health Technology

Health Technology